^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Diffuse Large B-cell Lymphoma: Useful in certain circumstances…Lenalidomide ± rituximab (non-GCB DLBCL)